Chief Administrative Law Judge D. Michael Chappell rejected the FTC’s position that the deal would hurt competition in the burgeoning market for multi-cancer early detection tests, handing a win to Illumina’s team at Cravath and GRAIL’s at Latham.
September 09, 2022 at 07:30 AM
12 minute read
Editor/columnist
Going to trial defending a merger before an administrative law judge at the U.S. Federal Trade Commission has typically been an against-all-odds sort of affair. Aside from the decision earlier this year in Altria’s $12.8 billion acquisition of a 35% stake in JUUL Labs Inc.—which wasn’t a full-blown merger case—you can’t find any such defense win.
That was until last week.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
(Top L-R)Christine Varney, David Marriott of Cravath, Swaine & Moore, (Bottom L-R)Mike Egge and Al Pfeiffer of Latham & Watkins. Courtesy photos
